サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1543978

移植診断学の世界市場

Transplant Diagnostics

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
移植診断学の世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

移植診断学の世界市場は2030年までに63億米ドルに到達

2023年に45億米ドルと推定される移植診断学の世界市場は、2023年から2030年にかけてCAGR 5.0%で成長し、2030年には63億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである分子アッセイ技術は、CAGR 5.7%を記録し、分析期間終了時には40億米ドルに達すると予測されます。非分子アッセイ技術分野の成長率は、分析期間中CAGR 4.0%と推定されます。

米国市場は12億米ドルと推定、中国はCAGR 8.8%で成長予測

米国の移植診断学市場は2023年に12億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに15億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8%と5.2%と予測されています。欧州では、ドイツがCAGR 2.2%で成長すると予測されています。

世界の移植診断学市場- 主要動向と促進要因まとめ

移植診断学とは何か、なぜ重要なのか？

移植診断学とは、臓器移植の適合性や健康状態を評価・監視するために使用される医療検査や処置のことです。これらの診断には、組織タイピング、クロスマッチング、拒絶反応や感染症を検出するための移植後のモニタリングなどが含まれます。移植診断学は、適切なドナーを特定し、拒絶反応を予防し、移植を受けた患者の健康を管理することにより、臓器移植の成功を確実にするために重要な役割を果たしています。これらの診断の正確さと信頼性は、移植の成果を向上させ、患者の生存率を高めるために不可欠です。

技術革新は市場にどのような影響を与えたか？

技術革新は移植診断学の分野を大きく前進させました。ポリメラーゼ連鎖反応（PCR）や次世代シークエンシング（NGS）などの分子診断技術の開発により、組織タイピングやクロスマッチングの精度とスピードが向上しました。これらの技術は、適合するドナーをより正確に同定し、拒絶反応の可能性を早期に発見することを可能にしています。バイオマーカー探索の進歩は、移植片の健康状態をモニタリングし、感染を検出するための非侵襲的検査の開発につながった。さらに、人工知能（AI）と機械学習アルゴリズムの統合により、データ分析と予測能力が強化され、移植患者の管理が改善されました。これらの技術的進歩は、移植診断学の範囲と効果を拡大し、臨床現場での採用を促進しています。

主要ユーザーとそのニーズは？

移植診断学の主要ユーザーには、移植センター、病院、診断研究所、研究機関が含まれます。移植センターと病院は、臓器移植の適合性と成功を保証するためにこれらの診断に依存しており、臨床判断の指針となる正確でタイムリーな結果を必要としています。診断研究所では、移植に関連する様々な検査が行われ、ハイスループットで信頼性の高い診断ツールが求められています。研究開発機関では、移植免疫学の研究や新しい診断・治療法の開発に移植診断学を利用し、高度で革新的な技術を求めています。それぞれのユーザーグループは、臓器移植に関わる複雑で重要なプロセスをサポートするために、高い精度、信頼性、使いやすさを提供する移植診断学を求めています。

移植診断学市場の成長の原動力は？

移植診断学市場の成長は、臓器移植の増加、診断技術の進歩、慢性疾患の有病率の上昇など、いくつかの要因によってもたらされます。臓器不全の発生率の増加や移植技術の向上により、臓器移植の需要が増加しているため、正確で信頼性の高い移植診断学の必要性が高まっています。分子診断やバイオマーカー探索などの診断技術の進歩により、移植診断学の精度とスピードが向上し、臨床現場での採用が促進されています。糖尿病や高血圧などの慢性疾患の蔓延が臓器不全の増加につながり、移植診断学の需要をさらに促進しています。さらに、移植研究や診断ツールの開発に対する政府の取り組みや資金援助が市場の成長を支えています。

調査対象企業の例（注目の11社）

  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffmann-La Roche AG
  • GenDx
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Omixon
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15303

Global Transplant Diagnostics Market to Reach US$6.3 Billion by 2030

The global market for Transplant Diagnostics estimated at US$4.5 Billion in the year 2023, is expected to reach US$6.3 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Molecular Assays Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Non-Molecular Assays Technology segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.8% CAGR

The Transplant Diagnostics market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Transplant Diagnostics Market - Key Trends & Drivers Summarized

What Are Transplant Diagnostics and Why Are They Critical?

Transplant diagnostics are medical tests and procedures used to evaluate and monitor the compatibility and health of organ transplants. These diagnostics include tissue typing, cross-matching, and post-transplant monitoring to detect rejection and infections. Transplant diagnostics play a crucial role in ensuring the success of organ transplants by identifying suitable donors, preventing rejection, and managing the health of transplant recipients. The accuracy and reliability of these diagnostics are essential for improving transplant outcomes and enhancing patient survival rates.

How Have Technological Innovations Impacted the Market?

Technological innovations have significantly advanced the field of transplant diagnostics. The development of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), has improved the accuracy and speed of tissue typing and cross-matching. These technologies enable more precise identification of compatible donors and early detection of potential rejection. Advances in biomarker discovery have led to the development of non-invasive tests for monitoring graft health and detecting infections. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms has enhanced data analysis and predictive capabilities, improving the management of transplant patients. These technological advancements have expanded the scope and effectiveness of transplant diagnostics, driving their adoption in clinical practice.

Who Are the Key Users and What Are Their Needs?

The key users of transplant diagnostics include transplant centers, hospitals, diagnostic laboratories, and research institutions. Transplant centers and hospitals rely on these diagnostics to ensure the compatibility and success of organ transplants, requiring accurate and timely results to guide clinical decisions. Diagnostic laboratories perform various transplant-related tests, demanding high-throughput and reliable diagnostic tools. Research institutions utilize transplant diagnostics to study transplant immunology and develop new diagnostic and therapeutic approaches, seeking advanced and innovative technologies. Each user group requires transplant diagnostics that offer high precision, reliability, and ease of use to support the complex and critical processes involved in organ transplantation.

What Is Driving Growth in the Transplant Diagnostics Market?

The growth in the transplant diagnostics market is driven by several factors, including the increasing number of organ transplants, advancements in diagnostic technologies, and the rising prevalence of chronic diseases. The growing demand for organ transplants, driven by the rising incidence of organ failure and improved transplant techniques, has increased the need for accurate and reliable transplant diagnostics. Advancements in diagnostic technologies, such as molecular diagnostics and biomarker discovery, have enhanced the precision and speed of transplant diagnostics, driving their adoption in clinical practice. The rising prevalence of chronic diseases, such as diabetes and hypertension, has led to an increase in organ failures, further fueling the demand for transplant diagnostics. Additionally, government initiatives and funding for transplant research and the development of diagnostic tools have supported market growth.

Select Competitors (Total 11 Featured) -

  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffmann-La Roche AG
  • GenDx
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Omixon
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transplant Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Organ Failures
    • Advancements in Molecular Diagnostics
    • Growth in Personalized Medicine
    • Development of Non-Invasive Diagnostic Tools
    • Rising Adoption of Genetic Testing
    • Expansion of Organ Transplant Programs
    • Innovations in Biomarker Discovery
    • Increasing Funding for Transplant Research
    • Growth in Point-of-Care Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Molecular Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Non-Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Non-Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Non-Molecular Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Reagent & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Reagent & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Reagent & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Transplant Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • INDIA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • AFRICA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION